Cellectis SA ADR buy melinda
Start price
17.08.17
/
50%
€20.11
Target price
28.08.17
€24.35
Performance (%)
23.86%
End price
28.08.17
€24.91
Summary
This prediction ended on 28.08.17 with a price of €24.91. The prediction had a final performance of 23.86%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -11.351% | -11.351% | 129.371% | 26.154% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% | 59.631% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% | 98.396% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% | 50.544% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% | 63.586% |
According to melinda what are the pros and cons of Cellectis SA ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Cellectis SA ADR diskutieren
zu folgen
$ CLLS UCART123 Patienten mit BPDCN ersten Phase - I - Studie am MD Anderson Cancer Center verwaltet
Stopped prediction by melinda for Cellectis SA ADR
Cellectis SA ADR
Start price
Target price
Perf. (%)
€2.32
07.10.22
07.10.22
€5.00
07.10.23
07.10.23
-43.97%
08.10.23
08.10.23
Could be worthwhile Investment >10% per year
Cellectis SA ADR
Start price
Target price
Perf. (%)
€6.75
11.01.22
11.01.22
€8.00
11.01.23
11.01.23
-65.63%
07.10.22
07.10.22
Could be worthwhile Investment >10% per year
Cellectis SA ADR
Start price
Target price
Perf. (%)
€29.87
14.03.18
14.03.18
€65.85
14.09.18
14.09.18
-16.61%
14.09.18
14.09.18
Could be worthwhile Investment >10% per year
Cellectis SA ADR
Start price
Target price
Perf. (%)
€27.85
06.05.16
06.05.16
€36.08
07.11.16
07.11.16
-44.32%
07.11.16
07.11.16
Could be worthwhile Investment >10% per year